CHDR

Leiden, Netherlands Founded: 1987 • Age: 39 yrs
Early-stage clinical drug research consulting services are provided.

About CHDR

CHDR is a Healthcare company based in Leiden (Netherlands) founded in 1987. Early-stage clinical drug research consulting services are provided. Its chief executive, as recorded, is Koos Burggraaf. Its website chdr.nl draws about 11 thousand monthly visits. CHDR offers products and services including NeuroCart®, PainCart®, and Clinical Trials Services. Its focus areas include Biopharma Outsourcing, Consulting and Clinical Development.

Company details

CHDR was established in 1987 in Leiden, Netherlands, within the clinical research sector. Services are focused on early-phase drug development, covering therapeutic areas including neurology, psychiatry, pain, sleep disorders, biology, dermatology, endocrinology, and pulmonology. Proprietary biomarkers such as NeuroCart and PainCart have been developed, alongside imaging techniques like PET, fMRI, and image-guided surgery support. Operations emphasize consulting for pharmaceutical clients.

  • Headquarters Leiden, Netherlands
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website chdr.nl
  • Social LinkedIn X Facebook
Key Metrics

Products & Services of CHDR

CHDR offers a comprehensive portfolio of products and services, including NeuroCart®, PainCart®, and Clinical Trials Services.

NeuroCart®
Neurological Assessment

Tool for evaluating neurological responses in clinical trials.

PainCart®
Pain Assessment

System for assessing pain sensitivity in drug research.

Clinical Trials Services
Research Support

Provides recruitment and data management for early-phase studies.

Funding Insights of CHDR

  • Total Rounds 2
  • Last Round Grant — $760,239
  • First Round $23,542

    (Aug 2019)

  • Investors Count 1

All 2 funding rounds of CHDR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2020$760,239Grant––
Aug 2019$23,542Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in CHDR

CHDR has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for CHDR

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CHDR

29 people are tracked at CHDR (8 in leadership, 21 in team).

NameRoleGroup
Koos Burggraaf
CEOLeadership
Anouk De Jong
Chief Financial OfficerLeadership
Geert Jan Groeneveld
Chief Executive OfficerLeadership
Maurits Vissers
Operations DirectorLeadership
Christine Van Andel
HR DirectorLeadership
Jeroen van Smeden
Director Of EducationLeadership
Wendy Post
HR Business PartnerLeadership
Rob Zuiker
Director Regulatory & Clinical ServicesLeadership
John Wimer
Software Development Team LeadTeam
Judith Manniën
Team Leader Data ProcessingTeam
Martje Kloosterboer
Call Agent RecruiterTeam
Jula Teunissen
CRU Administrative OfficerTeam
Debby van Leeuwen
Manager Clinical UnitTeam
Lisa Pagan
Clinical Study ManagerTeam
Thomas P.
Study NurseTeam
Aniek Wegner
Projectmanager RecruitmentTeam
Gitta Dirksen
Business Development MarketeerTeam
Kiki Los
CNS Study CoordinatorTeam
Cornelius Kruijsse
Senior Procurement ManagerTeam
Wouter Bakker
Clinical ScientistTeam

9 more people are available in the full profile.

Premium access

Complete people profiles for CHDR

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CHDR

3 dated milestones of CHDR across 33 years, from founding to its latest funding, stage changes and deals.

  1. Founded CHDR is founded.
  2. Funding First funding round of $24K.
  3. Funding Latest funding round, Grant, of $760K.

Web traffic of CHDR

The website of CHDR (chdr.nl) receives about 11K visits a month.

  • Monthly visits
    11K

    ▼ 15% vs previous month

Similar websites

Websites whose visitors overlap most with CHDR. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
proefpersoon.nl
proefpersoon.nl
100%
#406,758–
link2trials.com
88%
6.5K#2,949,970View details
castoredc.com
85%
167.7K#218,876View details
quintiles.com
74%
#377,823View details
qps.com
71%
19.2K#1,101,936View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 23 similar websites and full traffic analytics for CHDR

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 23 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Chdr

Premium access

Complete news archive for CHDR

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CHDR

CHDR was founded in 1987 and raised its 1st funding round 32 years after it was founded.

CHDR is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.

Koos Burggraaf is the CEO of CHDR, as recorded in our data.

CHDR was established in 1987 in Leiden, Netherlands, within the clinical research sector. Services are focused on early-phase drug development, covering therapeutic areas including neurology, psychiatry, pain, sleep disorders, biology, dermatology, endocrinology, and pulmonology. Proprietary biomarkers such as NeuroCart and PainCart have been developed, alongside imaging techniques like PET, fMRI, and image-guided surgery support. Operations emphasize consulting for pharmaceutical clients.

CHDR offers NeuroCart®, PainCart®, and Clinical Trials Services.

CHDR has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available